Antibodies to ribonucleoprotein, RNP, are found often in very high levels in patients with a variety of systemic rheumatic diseases, including SLE, progressive systemic sclerosis and Mixed Connective Tissue Disease, a distinct disease entity with overlapping clinical features of SLE, scleroderma, polymyositis and rheumatoid arthritis.
These autoantibodies usually give a strong speckled pattern of nuclear staining in immunofluorescence. The structure of the antigens recognised by anti-RNP antibodies is complex. The commonest determinants and ones which are most widely detected are those called RNP or U1RNP. Anti-RNP antibodies can be detected alone (usually in MCTD) or together with anti-Sm (lupus). Anti-Sm is seldom found alone.
What is mixed connective tissue disease?
Mixed Connective Tissue Disease (MCTD) is a complex autoimmune disorder characterized by symptoms that overlap with several other connective tissue diseases, such as systemic lupus erythematosus, scleroderma, and polymyositis. Individuals with MCTD may experience a wide range of symptoms including joint pain, swelling, muscle weakness, Raynaud's phenomenon (a condition where fingers and toes change color and may become painful in response to cold temperatures or stress), and skin and internal organ involvement. The disease can vary greatly in its presentation and severity, and its management typically involves treatments that suppress the immune system to reduce inflammation and control symptoms. The course of MCTD can be unpredictable; some patients may experience a mild form, while others may have a more progressive and severe disease.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.